Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Chemclin Diagnostics Co's Enterprise Value is ¥2,138.3 Mil.
Chemclin Diagnostics Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ¥51.9 Mil. Therefore, Chemclin Diagnostics Co's EV-to-EBIT ratio for today is 41.20.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Chemclin Diagnostics Co (SHSE:688468) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Chemclin Diagnostics Co's current Enterprise Value is ¥2,138.3 Mil.
Chemclin Diagnostics Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥51.9 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Chemclin Diagnostics Co's EV-to-EBITDA for today is:
Chemclin Diagnostics Co's current Enterprise Value is ¥2,138.3 Mil.
Chemclin Diagnostics Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥51.9 Mil.
Chemclin Diagnostics Co's current Enterprise Value is ¥2,138.3 Mil.
Chemclin Diagnostics Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥324.7 Mil.
Chemclin Diagnostics Co's current Enterprise Value is ¥2,138.3 Mil.
Chemclin Diagnostics Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥103.1 Mil.
Chemclin Diagnostics Co's current Enterprise Value is ¥2,138.3 Mil.
Chemclin Diagnostics Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥62.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chemclin Diagnostics Co Enterprise Value Related Terms
Chemclin Diagnostics Co Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688468 vs TMO, DHR, IDXX: Enterprise Value Comparison
For the Diagnostics & Research subindustry, Chemclin Diagnostics Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chemclin Diagnostics Co Enterprise Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Chemclin Diagnostics Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Chemclin Diagnostics Co's Enterprise Value falls into.
Chemclin Diagnostics Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Chemclin Diagnostics Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of ¥2,138.3 Mil mean?
Chemclin Diagnostics Co (SHSE:688468) has a Enterprise Value of ¥2,138.3 Mil as of Jul. 24, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Chemclin Diagnostics Co and its competitors.
Is Chemclin Diagnostics Co's Enterprise Value too high?
Chemclin Diagnostics Co's current Enterprise Value is ¥2,138.3 Mil. Overall, Chemclin Diagnostics Co has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chemclin Diagnostics Co's Enterprise Value compare to TMO and DHR?
Chemclin Diagnostics Co's Enterprise Value of ¥2,138.3 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Diagnostics & Research company?
A good Enterprise Value depends on the Medical Diagnostics & Research industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Chemclin Diagnostics Co and its competitors. Chemclin Diagnostics Co's current Enterprise Value is ¥2,138.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemclin Diagnostics Co stock overvalued right now?
Based on GuruFocus' analysis, Chemclin Diagnostics Co (SHSE:688468) is currently considered Fairly Valued. The stock's GF Value™ is ¥5.75, compared to a current price of ¥5.55 — trading 3.5% below its estimated fair value. The current Enterprise Value is ¥2,138.3 Mil. Chemclin Diagnostics Co's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Chemclin Diagnostics Co (SHSE:688468), the current Enterprise Value is ¥2,138.3 Mil as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chemclin Diagnostics Co (SHSE:688468) Overvalued in 2026?
Based on GuruFocus' analysis, Chemclin Diagnostics Co stock appears to be undervalued.
The current stock price of ¥5.55 is trading 3.5% below its estimated GF Value™ of ¥5.75.
GuruFocus considers Chemclin Diagnostics Co to be Fairly Valued.
Key valuation signals for SHSE:688468:
Enterprise Value: ¥2,138.3 Mil
GF Value™: ¥5.75 vs. price of ¥5.55 (3.5% below fair value)
No single metric tells the full story. See the SHSE:688468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chemclin Diagnostics Co Ltd is engaged in the development, production and sales of clinical immunochemiluminescence diagnostic testing reagents and instruments.
67GF Score
Get the complete analysis for SHSE:688468
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688468 has been successfully added to your 
